Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats

被引:64
作者
Kask, A
Pähkla, R
Irs, A
Rägo, L
Wikberg, JES
Schiöth, HB
机构
[1] Tartu State Univ, Dept Pharmacol, EE-2400 Tartu, Estonia
[2] Uppsala Univ, BMC, Dept Pharmaceut Pharmacol, S-75124 Uppsala, Sweden
关键词
food intake; HS014; leptin resistance; MC4; antagonist; melanocortin (MC) receptor subtypes; obesity;
D O I
10.1097/00001756-199903170-00009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
IN this study we investigated the long term effects of a potent and selective melanocortin 4 (MC4) receptor antagonist (HS014) on food intake, body weight, body composition and blood glucose levels in adult rats. HS014 was injected i.c.v. either by twice-daily injections (2 x 1 nmol) for 6 days or administered by continuous infusion with osmotic minipumps (0.16 nmol/h) for 2 weeks. The results show a considerable increase in food intake and body weight after both of the treatments without any signs of tachyphylaxis. After 2 weeks of treatment with osmotic pumps, the HS014-treated rats (average weight 425 g) had 20% higher body weight than the controls rats (average 360 g). When i.c.v. injections were terminated, the body weight of the twice-daily HS014-trrated rats returned to the levels of control group, whereas the rats treated with continuous infusion of HS014 remained hyperphagic and still gained weight. Blood glucose levels in the rats treated with HIS014 infusion were significantly increased. Analysis of body composition in HS014-infused rats indicated that body weight was increased due to fat deposits. These data show for the first time that chronic administration of exogenous MC4 receptor antagonist causes hyperphagia and severe obesity in rats. These data also indicate that the melanocortic control of food intake is very robust and suggest that changes induced by such treatment overcome negative feedback signals. NeuroReport 10: 711-711 (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:707 / 711
页数:5
相关论文
共 24 条
  • [1] BLUM WF, 1997, LEPTIN VOICE ADIPOSE, P318
  • [2] ALTERED EXPRESSION OF HYPOTHALAMIC NEUROPEPTIDE MESSENGER-RNAS IN FOOD-RESTRICTED AND FOOD-DEPRIVED RATS
    BRADY, LS
    SMITH, MA
    GOLD, PW
    HERKENHAM, M
    [J]. NEUROENDOCRINOLOGY, 1990, 52 (05) : 441 - 447
  • [3] Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor
    Chua, SC
    Chung, WK
    WuPeng, XS
    Zhang, YY
    Liu, SM
    Tartaglia, L
    Leibel, RL
    [J]. SCIENCE, 1996, 271 (5251) : 994 - 996
  • [4] Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
    Fan, W
    Boston, BA
    Kesterson, RA
    Hruby, VJ
    Cone, RD
    [J]. NATURE, 1997, 385 (6612) : 165 - 168
  • [5] Targeted disruption of the melanocortin-4 receptor results in obesity in mice
    Huszar, D
    Lynch, CA
    FairchildHuntress, V
    Dunmore, JH
    Fang, Q
    Berkemeier, LR
    Gu, W
    Kesterson, RA
    Boston, BA
    Cone, RD
    Smith, FJ
    Campfield, LA
    Burn, P
    Lee, F
    [J]. CELL, 1997, 88 (01) : 131 - 141
  • [6] Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats
    Kask, A
    Rägo, L
    Mutulis, F
    Pähkla, R
    Wikberg, JES
    Schiöth, HB
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (01) : 90 - 93
  • [7] Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight
    Kask, A
    Rägo, L
    Wikberg, JES
    Schiöth, HB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 360 (01) : 15 - 19
  • [8] Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024):: Evaluation in vitro and in vivo
    Kask, A
    Mutulis, F
    Muceniece, R
    Pähkla, R
    Mutule, I
    Wikberg, JES
    Rägo, L
    Schiöth, HB
    [J]. ENDOCRINOLOGY, 1998, 139 (12) : 5006 - 5014
  • [9] Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y
    Kask, A
    Rägo, L
    Korrovits, P
    Wikberg, JES
    Schiöth, HB
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (02) : 245 - 249
  • [10] Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the Agouti obesity syndrome
    Kesterson, RA
    Huszar, D
    Lynch, CA
    Simerly, RB
    Cone, RD
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (05) : 630 - 637